Carbohydrate-deficient glycoprotein syndrome

Area of Science:

• Biochemistry
• Genetics
• Neurology

Background:

• Carbohydrate-deficient glycoprotein syndrome (CDGS) is a rare inherited metabolic disorder.
• It presents with multisystemic involvement, notably neurological symptoms, developmental delay, and characteristic fat distribution.
• The clinical spectrum is diverse and appears more severe in infants.

Purpose of the Study:

• To summarize the current understanding of CDGS, including its clinical presentation, diagnosis, and underlying pathophysiology.
• To highlight the genetic and biochemical basis of the disorder.
• To discuss the implications for future research and clinical management.

Main Methods:

• Review of existing scientific literature on CDGS.
• Analysis of diagnostic criteria, including clinical and biochemical findings (isoelectric focusing of transferrin).
• Examination of reported enzyme defects and their association with CDGS types.

Main Results:

• CDGS involves abnormal synthesis of N-linked oligosaccharides, a fundamental metabolic defect.
• Two specific enzyme deficiencies identified: phosphomannomutase (Type I) and N-acetylglucosamine transferase II (Type II).
• Clinical heterogeneity suggests multiple defects within the N-linked oligosaccharide pathway.

Conclusions:

• Understanding the specific enzyme defects in CDGS is crucial for advancing research, including gene cloning and mutational analysis.
• Prenatal diagnosis may become available for affected families.
• Currently, management focuses on supportive care, nutrition, and family support, with ongoing research aiming for improved treatments.